Johnson & Johnson to Acquire Actelion in $30 Billion Deal
Johnson & Johnson will acquire the Swiss biotech firm Actelion at $30 billion. Acquiring Company: Johnson & Johnson Acquired Company: Actelion Deal Value: $30 billion... Read More
USFDA approval of Uptravi
Brand name: Uptravi Molecule: selexipag Type: Orphan Drug Indicated for: Treating adults with pulmonary arterial hypertension. (Pulmonary arterial hypertension, or PAH in short, is... Read More